Three Legs Tinea-Kare Anti-Fungal Spray & Cream (Antibacterial)
Three Legs Tinea-Kare is specially formulated with Clotrimazole that inhibits ergosterol synthesis. It has a broad antimycotic spectrum of in-vitro and in-vivo actions, which includes dermatophytes, yeasts, molds, and others.
The non-aerosol pump spray is a user-friendly option as it conveniently facilitates the application to hard-to-reach body areas. It is also hygienic and leaves no residue on the skin as the solution dries quickly, leaving a refreshing pine scent.
Tinea-Kare is also available as a cream for smaller infected areas of the skin.
For all dermatomycoses including athleteโs foot, jock itch, ringworm, candida vulvitis and skin diseases showing secondary infection with these fungi.
MAL Number
Tinea-Kare Spray: MAL 13115224XZ
Tinea-Kare Cream: MAL 13115221XZ
How to use :
1. The affected areas must be washed thoroughly dried.
2. A thin layer of the cream should be evenly rubbed into the affected areas twice daily.
3. Treatment should continue for 2 to 4 weeks after the disappearance of all signs of infection to ensure mycological cure and prevent relapse.
– Products Benefits/USP :
1. Effective anti-fungal agent
2. Relief of itch and inflammations.
3. Does not caused dryness or thinning of the skin
– Products Specification :10g
Three Legs Tinea-Kareๆฏ็นๅซ้
ๅถ็๏ผๅซๆๅ
้ๅ๏ผClotrimazole๏ผ๏ผๅฎๆๅถ้บฆ่ง้
ฎๅๆใๅฎๅจไฝๅ
ๅไฝๅค้ฝๅ
ทๆๅนฟๆณ็ๆ็่ไฝ็จ่ฐฑ๏ผๅ
ๆฌ็ฎ่ค็่ใ้
ตๆฏใ้่็ญใ
้ๆฐ้พๆณตๅท้พๆฏ็จๆทๅๅฅฝ็้ๆฉ๏ผๅ ไธบๅฎๆนไพฟๅฐ็จไบ้พไปฅๅฐ่พพ็่บซไฝ้จไฝใๅฎ่ฟๅ
ทๆๅซ็ๆง๏ผๅ ไธบๆบถๆถฒ่ฟ
้ๅนฒ็ฅ๏ผไธไผๅจ็ฎ่คไธ็ไธๆฎ็็ฉ๏ผ่ๆฏ็ไธๆธ
ๆฐ็ๆพๆ ้ฆๅณใ
Tinea-Kareไนๆไพไฝไธบ้ๅ๏ผ็จไบ็ฎ่คไธ่พๅฐ็ๆๆๅบๅใ
้็จไบๆๆ็ฎ่ค็่ๆๆ๏ผๅ
ๆฌ่ฟๅจๅ่ถณใ่
น่กๆฒ็็ใ็ฃใๅฟต็ ่ๆงๅค้ด็ไปฅๅๆพ็คบ่ฟไบ็่ไบๆฌกๆๆ็็ฎ่ค็พ็
ใ
MALๅท๏ผ
Tinea-Kare ๅท้พ๏ผMAL 13115224XZ
Tinea-Kare ้ๅ๏ผMAL 13115221XZ
ไฝฟ็จๆนๆณ๏ผ
ๅๅฝฑๅ็ๅบๅๅฟ
้กปๅฝปๅบๆธ
ๆดๅนถๆพๅนฒใ
่่็้ๅๅบๅๅๆถๆนๅจๅๅฝฑๅ็ๅบๅ๏ผๆฏๅคฉไธคๆฌกใ
ๅจๆๆๆๆ่ฟน่ฑกๆถๅคฑๅ๏ผๆฒป็ๅบๆ็ปญ2่ณ4ๅจ๏ผไปฅ็กฎไฟ็่็ๆๅนถ้ข้ฒๅคๅใ
ไบงๅๅฅฝๅค/็ฌ็นๅ็น๏ผ
ๆๆ็ๆ็่ๅ
็ผ่งฃ็็ๅ็็
ไธไผๅฏผ่ด็ฎ่คๅนฒ็ฅๆๅ่
ไบงๅ่งๆ ผ๏ผ10ๅ
There are no reviews yet.